Sacramento, California
United States
43
2026-01-29
The entities that hold a legal rights for patent applications filed by inventor Brams Peter:
Peter Brams from Sacramento, US has applied for patents for these inventions. The list has both pending applications and granted patents:
HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES
#2 | 2026-01-22HUMAN IMMUNOGLOBULIN COMMON LIGHT CHAIN TRANSGENE CONSTRUCTS AND USES THEREOF
#3 | 2024-08-08HUMAN IMMUNOGLOBULIN BINARY LIGHT CHAIN TRANSGENE CONSTRUCTS AND USES THEREOF
#4 | 2024-08-08CHIMERIC TRANSGENIC IMMUNOGLOBULIN MICE WITH AN ALTERED HEAVY CHAIN LOCUS AND METHODS OF MAKING AND USING SAME
#5 | 2024-07-18HUMAN IMMUNOGLOBULIN HEAVY CHAIN LONG CDR3 TRANSGENE CONSTRUCTS AND USES THEREOF
#6 | 2022-12-22HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES
#7 | 2022-12-08TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF
#8 | 2022-01-06BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR
#9 | 2019-10-31Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
#10 | 2019-10-17HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES
#11 | 2019-05-09BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR
#12 | 2019-01-31Human monoclonal antibodies that bind CXCR4 and uses thereof
#13 | 2018-03-01Binding molecules to the human OX40 receptor
#14 | 2018-02-22TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF
#15 | 2017-07-06HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES
#16 | 2016-01-28Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies
#17 | 2015-08-06Binding molecules to the human OX40 receptor
#18 | 2015-07-23ANTIBODIES TO IL-6 AND THEIR USES
#19 | 2015-05-14Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
#20 | 2014-06-05ALPHA5-BETA1 ANTIBODIES AND THEIR USES
#21 | 2013-10-24Antibodies to IL-6 and their uses
#22 | 2013-09-26Nucleic acids encoding human monoclonal antibodies that bind CXCR4
#23 | 2013-06-06Human monoclonal antibodies to Fucosyl-GM1 and methods for using anti-Fucosyl-GM1 antibodies
#24 | 2012-10-25Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#25 | 2012-09-06Binding molecules to the human OX40 receptor
#26 | 2012-08-09Antibodies to IL-6 and their uses
#27 | 2012-01-12Alpha5-beta1 antibodies and their uses
#28 | 2011-08-25Binding molecules to the human OX40 receptor
#29 | 2011-07-07GPCR crystalization method using an antibody
#30 | 2011-06-09Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#31 | 2011-03-10Neutralizing human anti-IGFR antibody
#32 | 2011-01-20ANTI-IGF1R
#33 | 2010-12-30Alpha 5-beta 1 antibodies and their uses
#34 | 2010-11-25Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1
#35 | 2010-04-29Human monoclonal antibodies that bind CXCR4
#36 | 2009-12-24Antibodies to IL-6 and their uses
#37 | 2009-10-15Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#38 | 2009-08-27Binding molecules to the human OX40 receptor
#39 | 2009-06-11Method for obtaining G protein-coupled receptor (GPCR) diffraction-quality crystals employing a monoclonal antibody that binds to the third intracellular loop (IL3)
#40 | 2008-01-17Neutralizing human anti-IGFR antibody
#41 | 2007-05-15Neutralizing human anti-IGFR antibody
#42 | 2007-03-15Neutralizing human anti-IGFR antibody
#43 | 2007-03-15Neutralizing human anti-IGFR antibody
455173 ⎘